BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10524408)

  • 1. Effect of post-implant edema on the rectal dose in prostate brachytherapy.
    Waterman FM; Dicker AP
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):571-6. PubMed ID: 10524408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate.
    Yue N; Dicker AP; Corn BW; Nath R; Waterman FM
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):447-54. PubMed ID: 10030274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
    Yue N; Chen Z; Peschel R; Dicker AP; Waterman FM; Nath R
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1063-72. PubMed ID: 10571216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prostatic edema on CT-based postimplant dosimetry.
    Dogan N; Mohideen N; Glasgow GP; Keys K; Flanigan RC
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):483-9. PubMed ID: 12023153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition.
    Waterman FM; Yue N; Corn BW; Dicker AP
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1069-77. PubMed ID: 9719117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.
    Prestidge BR; Bice WS; Kiefer EJ; Prete JJ
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1111-5. PubMed ID: 9539566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of postimplant edema on the urethral dose in prostate brachytherapy.
    Waterman FM; Dicker AP
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):661-4. PubMed ID: 10837949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal dosimetric analysis following prostate brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Lief JH; Walbert HL; Blatt HJ
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1021-7. PubMed ID: 10192350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of edema on planning 125I and 103Pd prostate implants.
    Yue N; Dicker AP; Nath R; Waterman FM
    Med Phys; 1999 May; 26(5):763-7. PubMed ID: 10360539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probability of late rectal morbidity in 125I prostate brachytherapy.
    Waterman FM; Dicker AP
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):342-53. PubMed ID: 12527047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of postimplant edema on V(100) and D(90) in prostate brachytherapy: can implant quality be predicted on day 0?
    Waterman FM; Dicker AP
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):610-21. PubMed ID: 12062604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edema-induced increase in tumour cell survival for 125I and 103Pd prostate permanent seed implants--a bio-mathematical model.
    Yue N; Chen Z; Nath R
    Phys Med Biol; 2002 Apr; 47(7):1185-204. PubMed ID: 11996063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal-wall dose dependence on postplan timing after permanent-seed prostate brachytherapy.
    Taussky D; Yeung I; Williams T; Pearson S; McLean M; Pond G; Crook J
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):358-63. PubMed ID: 16563654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isotope choice and the effect of edema on prostate brachytherapy dosimetry.
    Butler WM; Merrick GS; Dorsey AT; Lief JH
    Med Phys; 2000 May; 27(5):1067-75. PubMed ID: 10841411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of methods for calculating rectal dose after (125)I prostate brachytherapy implants.
    Hilts M; Spadinger I; Keyes M
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):775-85. PubMed ID: 12062624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seed fixity in the prostate/periprostatic region following brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Lief JH; Benson ML
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):215-20. PubMed ID: 10656395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103.
    Taggar AS; Charas T; Cohen GN; Boonyawan K; Kollmeier M; McBride S; Mathur N; Damato AL; Zelefsky MJ
    Brachytherapy; 2018; 17(2):251-258. PubMed ID: 29241706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachytherapy in patients with small prostate glands.
    Loblaw DA; Wallner K; Dibiase S; Russell K; Blasko J; Ellis W
    Tech Urol; 2000 Jun; 6(2):64-9. PubMed ID: 10798802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perirectal seeds as a risk factor for prostate brachytherapy-related rectal bleeding.
    Mueller A; Wallner K; Merrick G; Ford E; Sutlief S; Cavanagh W; Butler W
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1047-52. PubMed ID: 15234038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of edema on the post-implant dosimetry of an I-125 prostate implant: a case study.
    Waterman FM; Yue N; Reisinger S; Dicker A; Corn BW
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):335-9. PubMed ID: 9226320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.